Impact of COVID‐19 in immunosuppressive drug‐naïve autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease

Few conflicting data are currently available on the risk of SARS‐CoV‐2 infection in patients with autoimmune disorders. The studies performed so far are influenced, in most cases, by the treatment with immunosuppressive drugs, making it difficult to ascertain the burden of autoimmunity per se. For t...

Descripción completa

Detalles Bibliográficos
Autores principales: Santacroce, Giovanni, Lenti, Marco Vincenzo, Aronico, Nicola, Miceli, Emanuela, Lovati, Elisabetta, Lucotti, Pietro Carlo, Coppola, Luigi, Gentile, Antonella, Latorre, Mario Andrea, Di Terlizzi, Francesco, Soriano, Simone, Frigerio, Chiara, Pellegrino, Ivan, Pasini, Alessandra, Ubezio, Cristina, Mambella, Jacopo, Canta, Roberta, Fusco, Alessandra, Rigano, Giovanni, Di Sabatino, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Special Issue: 2021 Update From The Italian Society Of Pediatric Allergy And Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305940/
https://www.ncbi.nlm.nih.gov/pubmed/35080315
http://dx.doi.org/10.1111/pai.13646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305940/
https://www.ncbi.nlm.nih.gov/pubmed/35080315
http://dx.doi.org/10.1111/pai.13646

Ejemplares similares